TipRanks Reveals The Top 10 Health Care Sector Analysts Of The Past Decade

Oleh Admin 22 Mei, 2023 Posting Komentar

A customer uses an automated teller machine (ATM) at a Trust Bank branch in Dallas, Texas on Friday, April 14, 2023.

The healthcare industry has evolved rapidly over the past decade with digital services offering a variety of investment opportunities.

TipRanks honors the top ten Wall Street analysts in the industry to identify the best investment opportunities. These analysts outperformed their peers in their stock selections and earned higher returns on their recommendations.

TipRanks used the Expert Center tool to identify top achievers. We've also analyzed every stock recommendation healthcare analysts have made over the past ten years.

The ratings reflect analysts' ability to generate returns from the offerings. Tipranks algorithms calculate statistical significance, mean return, and analysts' overall success ratio for each level. In addition, each level is measured over a period of one year.

Top 10 health analysts

The figure shows the top-performing healthcare analysts on Wall Street, in order.

1. Thomas Smith - SVB Securities

Thomas Smith tops the list. Smith's overall success rate is 51 percent. His senior position was at Viking Therapeutics ( NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the treatment of metabolic and endocrine diseases. His long call on VKTX shares from April 27, 2022 to April 27, 2023 yielded a nice return of 791.30 percent.

2. Brandon Couillard-Jeffer

Brandon Couillard is second on this list with a 68 percent success rate. Couillard's top pick is Exact Sciences ( NASDAQ: EXAS ), a provider of cancer diagnostics and diagnostic tests. From May 4, 2016 to May 4, 2017, the analyst returned 450% from his Buy rating on Exact Sciences stock.

3. David Windley-Jeffer

Jefferies analyst David Windley is third on the list. Windley has a 68% success rate. His top recommendation was Medidata Solutions, a technology-based clinical expertise. Subsequently, Dassault Systèmes acquired Medidata. The analyst created a 175.70% buy recommendation change in MDSO from 08/01/2012 to 08/01/2013.

4. John Ede - Argus Research

John Ede is fourth on the list. The overall success rate for a five-star analyst is 69 percent. Ede's first choice was pharmaceutical and biotechnology company Moderna ( NASDAQ: MRNA ). The call on mRNA stock returned 265.90% from June 30, 2020 to June 30, 2021.

5. Michael Wiederhorn-Oppenheimer

The fifth analyst, Michael Wiederhorn, has a 66% hit rate. His top pick is Community Health Systems ( NYSE: CYH ), a company that manages and operates hospitals. The analyst forecast this stock to grow by 298.2% from May 1, 2020 to May 1, 2021.

6. Charles Duncan - Cantor Fitzgerald

Charles Duncan takes sixth place. Analysts' success rate is 52%. His CEO was Novavax ( NASDAQ:NVAX ), a biotechnology company developing vaccines. For his call on NVAX stock, Duncan posted a solid return of 800% from March 17, 2020 to March 17, 2021.

7. Jaron Werber - TD Cowen

TD Cowen analyst Jaron Varber ranks seventh with a 65% success rate. Verber's best decision was to buy shares in Ultragenyx Pharmaceutical ( NASDAQ: RARE ), a biopharmaceutical company focused on developing innovative drugs for rare and extremely rare diseases. The offering made a return of 267.50% from December 18, 2019 to December 18, 2020.

8. From Geulah Livsh - the capital of Chardan

Charda Capital's Geulah Livshitz is in eighth place. Livshitz's overall success rate is 42 percent. The analyst's top pick is Cabaletta Bio ( NASDAQ: CABA ), a clinical-stage biotech focused on developing treatments for autoimmune diseases. Based on the call to CABA, the analyst has returned 800% since October 11, 2022.

9. Richard Newiter - Financial Truist

Richard Neuter is ninth on the list. A five-star analyst has a 62% success rate. His top pick was Organogenesis ( NASDAQ: ORGO ), a regenerative medicine company that offers advanced wound care and surgical biologics. The auction offering has returned 397.9% from May 12, 2020 to May 12, 2021.

10. Boris Elector - TD Cowen

Boris Picker is ranked 10th with a 47 percent success rate. Packer's best decision was to buy shares in Trillium Therapeutics, a company developing clinical-stage cancer treatments. Pfizer ( NYSE: PFE ) then acquired Trillium. The offer has 800% return from January 7, 2020 to January 7, 2021.

dead end

Investors can follow the recommendations of leading analysts to make informed investment decisions. You can also see all analysts who made the top 100 list. We'll be back soon with the top 10 consumer goods analysts of the last 10 years.

Health Benefits